跳至主要内容
临床试验/ACTRN12611000513910
ACTRN12611000513910已完成4 期

The effectiveness of Response-guided therapy strategies in recent hepatitis C infection

The University of New South Wales (acting through the Kirby Institute, formerly the National Centre in HIV Epideiology and Clinical Research))0 个研究点目标入组 120 人开始时间: 2011年5月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Male and female subjects >= 16 years of age
  • To have recently acquired HCV infection as defined below:
  • i) First anti-HCV antibody or HCV RNA positive within the previous 6 months
  • ii) Documented anti-HCV antibody negative within the 24 months prior to anti-HCV antibody positive result
  • i) First anti-HCV antibody or HCV RNA positive within the previous 6 months
  • ii) acute clinical hepatitis (jaundice or ALT> 10 X ULN) within the previous 12 months prior to first positive HCV antibody or HCV RNA, with no other cause of acute hepatitis identifiable

排除标准

  • Individuals considered by the study investigators to be unlikely to participate in intensive follow-up and/or unwilling to provide extra blood samples, and standard exclusion criteria for pegylated interferon alfa-2a and ribavirin.

研究者

发起方
The University of New South Wales (acting through the Kirby Institute, formerly the National Centre in HIV Epideiology and Clinical Research))

相似试验